UMOD NKCC2 interaction therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UMOD NKCC2 interaction therapy, covering 2023-09-25 to 2023-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension [Phase 4]